FibroBiologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Selling, General & Admin	6.52	3.32	1.06
Research & Development	2.37	1.15	0.52
Operating Expenses	8.89	4.47	1.58
Operating Income	-8.89	-4.47	-1.58
Interest Expense / Income	0.15	0.65	0
Other Expense / Income	7.45	-	-
Pretax Income	-16.49	-5.12	-1.58
Net Income	-16.49	-5.12	-1.58
Preferred Dividends	2.57	0	0
Net Income Common	-19.06	-5.12	-1.58
Shares Outstanding (Basic)	28	28	-
Shares Outstanding (Diluted)	28	28	-
EPS (Basic)	-0.68	-0.18	-
EPS (Diluted)	-0.68	-0.18	-
Free Cash Flow	-6.9	-4.07	-1.41
Free Cash Flow Per Share	-0.24	-0.14	-
EBITDA	-15.9	-4.37	-1.58
Depreciation & Amortization	0.44	0.09	0
EBIT	-16.34	-4.47	-1.58

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).